Human research capacity in Chinese agbiotech
نویسندگان
چکیده
منابع مشابه
LL_Transatlantic Agbiotech Conflict
Since the early 1990s the US government policy has treated agbiotech as technological progress yielding beneficial products which warrant no special label, and whose safety can be readily demonstrated through ‘sound science’. Federal agencies readily approved or deregulated GM crops for cultivation and other uses. Food regulators routinely accepted company claims that GM foods had substantial e...
متن کاملMaking Europe Unsafe for Agbiotech
Since the 1980s biotechnology has been promoted as a symbol of European progress. As a clean technology, agbiotech was meant to enhance efficient agri-production and thus fulfil the beneficent promise of a European Biosociety, like its counterpart of the Information Society. By the early 1990s biotech symbolised the ‘knowledge-based society’ and eventually the Lisbon agenda. At the 2000 Lisbon ...
متن کاملResearch Capacity at Traditional Chinese Medicine (TCM) Centers in China: A Survey of Clinical Investigators
Background. The development of an evidence-based approach to traditional Chinese medicine (TCM), which depends on the generation of good quality evidence, requires an adequate workforce. However, the research capacity of TCM investigators is not known. Study Design. This cross-sectional study was conducted to describe the research capacity of TCM clinical investigators in China. Participants. A...
متن کاملEXPRESSION OF HUMAN PROTEINASE 3 IN CHINESE HAMSTER OVARY CELLS (CHO-CELLS)
Proteinase 3(PR3) is a human polymorphonuclear leukocyte serine proteinase and is the main target antigen for antineutrophil cytoplasmic antibodies (ANCA) found in Wegener's granulomatosis (WG). We developed a stable expression system for conformationally intact recombinant PR3 (rPR3) in Chinese hamster ovary cells (CHO-cells). The part of PR3 cDNA that encoded the active form of PR3 was s...
متن کاملDemocratizing Agri-Biotechnology? European public participation in agbiotech assessment
Anticipating or responding to European public concerns over agbiotech, state bodies have sponsored participatory exercises in technology assessment (TA). Some participants have sought to open up technological decisions vis-à-vis alternative futures and normative choices, but such efforts have been marginalized; the trajectory of biotechnological innovation has been protected from challenge. Que...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Biotechnology
سال: 2012
ISSN: 1087-0156,1546-1696
DOI: 10.1038/nbt.2386